J Desmyter

Key Performance Indicators For The Indoor Environment.

Mglc Marcel Loomans, Aapo Huovila, P-H Lefebvre, 2011 .

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.

J Desmyter, E. De Clercq, R. Pauwels, 1988, Journal of virological methods.

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.

J Desmyter, E. De Clercq, R. Pauwels, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes.

J Desmyter, M. Salemi, A. Vandamme, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains.

J Desmyter, M. Salemi, A. Vandamme, 1998, Virology.

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of tetrahydro-imidazo[4,5,1-JK][1,4]-benzzodiazepin-2(1H)-one and -thione (TIBO) derivatives

J Desmyter, Rudi Pauwels, R. Pauwels, 1990 .

EVALUATION OF SIX ENZYME IMMUNOASSAYS FOR ANTIBODY AGAINST HUMAN IMMUNODEFICIENCY VIRUS

J Desmyter, C. Aaij, H. Reesink, 1986, The Lancet.

Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

J Desmyter, E. De Clercq, R. Pauwels, 1987, Biochemical and biophysical research communications.

Evaluating Clinical Isolates for Their Phenotypic and Genotypic Resistance Against Anti-HIV Drugs.

J Desmyter, E. De Clercq, C. Pannecouque, 2000, Methods in molecular medicine.